Clinical trial / 2008
Soy protein consumption led to lower prostate cancer detection compared with milk protein.
In a randomized trial, 58 men at risk of or with low-grade prostate cancer consumed 40 g daily of isoflavone-rich soy protein, alcohol-washed soy protein, or milk protein for 6 months. Serum PSA and prostate tissue biomarkers did not change with isoflavone-rich soy protein, whereas Bax expression decreased with alcohol-washed soy. A significantly lower rate of prostate cancer was detected in the soy groups compared to the milk group (P = 0.01).
- Study type
- Randomized controlled trial
- Who was studied
- 58 men at high risk of or with low-grade prostate cancer
- What was measured
- Prostate tissue biomarkers, PSA, and prostate cancer diagnosis
THE PAPER
Effects of soy protein isolate consumption on prostate cancer biomarkers in men with HGPIN, ASAP, and low-grade prostate cancer.
Hamilton-Reeves JM, Rebello SA, Thomas W, Kurzer MS, Slaton JW. Nutr Cancer, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.